Analgésie à effet prolongé grâce à l'administration transdermale de la buprénorphine

• 收藏
• 分享

专利权人:

EURO-CELTIQUE S.A.

发明人:

申请号：

EP06118876.9

公开号：

EP1731152B1

申请日:

1998.02.24

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

A sustained release formulation of buprenorphine is new. The composition comprises a transdermal delivery device which provides a first order release of buprenorphine over a 3-day dosing interval so that a maximum plasma concentration of 20 10 1052 pg/ml is obtained. the device then provides zero order kinetics over at least 2 more days.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/